is glp-1 safe to use Injections for Medical Weight Loss Near Me GLP-1 Receptor Agonists and Research

OTHERS Recent investigations have elucidated a multifaceted spectrum of adverse effects linked to GLP-1 RAs (Table 1), necessitating meticulous interpretation based on the various methodological designs employed, including RCTs and retrospective analyses

Strong results in appetite suppression and improved metabolic health are demonstrated by clinical studies

Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks

Ask questions to deepen your comprehension, such as the specific GLP-1 medication options available, their potential side effects, and how they may interact with any other medications or conditions you have